GlassScriptPhysician profile
Obi Osuji
NPI 1730321985
$11,034.82
in general payments reported to CMS, 2019-2025
24 companies · $3,831 in 2025
The $3,831 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $226 · 2022: $2,594 · 2023: $2,944 · 2024: $1,076 · 2025: $3,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,851 · Travel and Lodging: $3,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,851.03 |
| Travel and Lodging | $3,001.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corentec America INC | $2,599.94 | 2024-2025 | Corentec |
| Stryker Corporation | $2,256.52 | 2022-2025 | Mako, Gamma, Hydroset |
| Pylant Medical | $1,653.99 | 2022-2025 | |
| Smith+Nephew, INC. | $1,612.93 | 2023 | Legion, Redapt, Real Intelligence |
| Acumed LLC | $747.37 | 2025 | Acumed |
| Ortho Development Corporation | $673.12 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $448.18 | 2019-2020 | |
| Restor3d, INC. | $234.47 | 2025 | |
| Depuy Synthes Sales INC. | $145.96 | 2019-2024 | Tfn-Advance, Na |
| Orthalign INC | $126.43 | 2023 | Orthalign Plus |
| Arthrex, INC. | $108.00 | 2024 | |
| Davol INC. | $86.67 | 2025 | Arista |
| Conformis, INC. | $58.50 | 2019 | |
| Si-Bone, INC. | $47.00 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $46.90 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $40.70 | 2025 | Xcell |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.79 | 2019 | |
| Orthofix Medical, INC. | $20.37 | 2022 | |
| Globus Medical, INC. | $20.14 | 2023 | Ankle Fracture System |
| Fidia Pharma USA INC. | $15.91 | 2019 | |
| Medtronic, INC. | $15.82 | 2023 | Intellis Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $15.20 | 2025 | Exparel |
| Kowa Pharmaceuticals America, INC. | $14.07 | 2022 | |
| Amgen INC. | $13.84 | 2023 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Obi Osuji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.